Research Progress of Targeted Therapy for EGFR Gene in Non-small Cell Lung Cancer
10.3779/j.issn.1009-3419.2017.01.09
- VernacularTitle:非小细胞肺癌EGFR基因靶向治疗研究进展
- Author:
ZHANG HUI
1
;
ZHANG SHUCAI
Author Information
1. 首都医科大学附属北京胸科医院/北京市结核病胸部肿瘤研究所肿瘤内科
- Keywords:
Lung neoplasms;
Epidermal growth factor receptor;
Mutation;
Targeted therapy
- From:
Chinese Journal of Lung Cancer
2017;20(1):61-65
- CountryChina
- Language:Chinese
-
Abstract:
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have brought great clinical beneift to patients with EGFR-sensitive mutations. With the deepening of clinical and basic research, EGFR-TKIs have received more and more attention. In this review, we summarize the latest research development about EGFR-targeted drugs in 2016.
